540 related articles for article (PubMed ID: 18588495)
1. Antibiotic options for treating community-acquired MRSA.
Powell JP; Wenzel RP
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
[TBL] [Abstract][Full Text] [Related]
2. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Chambers HF
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
[TBL] [Abstract][Full Text] [Related]
3. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
4. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
Khawcharoenporn T; Alan T
Hawaii Med J; 2006 Oct; 65(10):290-3. PubMed ID: 17194061
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
Marcinak JF; Frank AL
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):91-100. PubMed ID: 16441212
[TBL] [Abstract][Full Text] [Related]
6. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA
Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
[TBL] [Abstract][Full Text] [Related]
7. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
Sabol KE; Echevarria KL; Lewis JS
Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661
[TBL] [Abstract][Full Text] [Related]
8. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
Pichereau S; Rose WE
Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116
[TBL] [Abstract][Full Text] [Related]
9. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Creech CB; Beekmann SE; Chen Y; Polgreen PM
Pediatr Infect Dis J; 2008 Mar; 27(3):270-2. PubMed ID: 18277924
[TBL] [Abstract][Full Text] [Related]
10. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
11. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
Ruhe JJ; Smith N; Bradsher RW; Menon A
Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin: rationale and role in the management of skin and soft tissue infections.
Seaton RA
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
[TBL] [Abstract][Full Text] [Related]
14. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
Moellering RC
Clin Infect Dis; 2008 Apr; 46(7):1032-7. PubMed ID: 18444820
[TBL] [Abstract][Full Text] [Related]
15. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.
Fergie J; Purcell K
Pediatr Infect Dis J; 2008 Jan; 27(1):67-8. PubMed ID: 18162942
[No Abstract] [Full Text] [Related]
16. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
17. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL
Semin Pediatr Infect Dis; 2006 Jul; 17(3):113-9. PubMed ID: 16934705
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for complicated skin and skin-structure infections.
Mendoza N; Tyring SK
Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center.
Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z
Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235
[TBL] [Abstract][Full Text] [Related]
20. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.
Cunha BA
Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
